Populus Global Solutions Inc.: federal grants and contributions: 17 agreements; $2.7M value; 2 departments; 9 programs.
Assay record ASY-CA-0F0YPKF1LA · Cite as: Assay Systems, “Populus Global Solutions Inc.: federal grants and contributions”, https://assay-systems.com/register/ca/grants/r/populus-global-solutions-inc/
Commercialization of additional product offerings Populus Plus and Populus Solutions
Develop solutions for community and specialty clinics in the United States
Develop marketing materials for E-Health software
The project is focused on the advancement of the Populus Plus product targeted at the growing opportunities in Translational Lab Research. Through the initial establishment of a collaborative business relationship with Dr Kevin Garey, the Chair of the University of Houston (UoH) College of Pharmacy, it has been determined that the Populus Plus product, with its focus on disease management and population health capabilities, can enable clinical researchers to collect, organize, and access pertinent data that will lead to effective and critical collaboration resulting in improving disease outcom
Undertake commercialization and marketing activities
Engage a consultant to support the development of a new data management method
Provide assistance to mitigate impacts of Covid-19
This project will extend a Canadian standards-based health data platform by enabling an operational exemplar registry and establishing the core structures needed for future multi-registry scaling. It advances the platform delivered in Project 1 by strengthening data flows, security, terminology integration, and deployment efficiency. The project will deliver an IBD(Inflammatory Bowel Disease) registry template, improved setup materials, and a technical readiness package that supports commercialization and adoption by Canadian health organizations.
This project will deploy a standards-based, health data exchange and analytics platform for the Canadian context. With support from NRC IRAP, the project will localize the platform to meet Canadian standards providing utility for clinical integration, analytics, and registry development. The goal is to showcase the ingestion, transformation, and visualization capabilities of the stack, setting the stage for future disease-specific registry implementations. This will position it for broader adoption and commercialization in the Canadian health system.
Hire expertise
Hire a business development consultant
Engage a business development consultant
Engage a consultant to support strategic growth
The purpose of this CanExport SMEs agreement is to support small- and medium-sized enterprises (SMEs) for activities related to export market development that are part of an export business case for a specific target market, particularly where activities are targeting departmental priority markets and sectors.
The project will establish a reusable core model with adaptable extensions, assess data mapping across source systems, and ensure compatibility with downstream analytics. This approach will enable more efficient deployment of future registries and support a more consistent, scalable clinical data platform.
Contains information licensed under the Open Government Licence – Canada. Source: Government of Canada proactive disclosure of grants and contributions (open.canada.ca, dataset 432527ab-7aac-45b5-81d6-7597107a7013), 1,327,352 rows as published, collapsed to one agreement per agreement number (per reference number where none is given) at its latest amendment, which carries the full agreement value. Years are the agreement start year. Agreements with individuals are counted but not named.